-
1دورية أكاديمية
المؤلفون: WALLEMACQ, Caroline, Scheen, André
المصدر: Revue Médicale de Liège, 75 (4), 260-264 (2020)
مصطلحات موضوعية: Anticholesteremic Agents/administration & dosage, Belgium, Cholesterol, LDL, Drug Therapy, Combination, Ezetimibe/administration & dosage, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia/drug therapy, Rosuvastatin Calcium/administration & dosage, Treatment Outcome, Cardiovascular, Cholesterol, Ezetimibe, Fixed, Rosuvastatin, dose combination, Human health sciences, Pharmacy, pharmacology & toxicology, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Pharmacie, pharmacologie & toxicologie, Endocrinologie, métabolisme & nutrition
Relation: urn:issn:0370-629X; urn:issn:2566-1566
URL الوصول: https://orbi.uliege.be/handle/2268/246847
-
2
المؤلفون: António Miguel Ferreira, Pedro Marques da Silva
المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAPمصطلحات موضوعية: Oncology, Simvastatin, medicine.medical_specialty, Statin, Combination therapy, HSM MED, medicine.drug_class, Atorvastatin, Drug Therapy, Combination/methods, Hyperlipidemias, 030204 cardiovascular system & hematology, Simvastatin/administration & dosage, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Ezetimibe, Anticholesteremic Agents/administration & dosage, Internal medicine, Ezetimibe/atorvastatin, Hyperlipidemia, medicine, Humans, Pharmacology (medical), Atorvastatin Calcium/administration & dosage, cardiovascular diseases, 030212 general & internal medicine, Cholesterol, HDL/blood, Hyperlipidemias/drug therapy, Cholesterol, business.industry, Anticholesteremic Agents, Ezetimibe/administration & dosage, Cholesterol, HDL, Hyperlipidemias/blood, nutritional and metabolic diseases, Cholesterol, LDL, General Medicine, medicine.disease, Endocrinology, Cholesterol, LDL/blood, chemistry, Drug Therapy, Combination, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, business, Dyslipidemia, medicine.drug
-
3
المؤلفون: Nicolas Rodondi, Dik Heg, Thomas F. Lüscher, François Mach, Stephan Windecker, Christian M. Matter, Lorenz Räber, Alexios Karagiannis, David Carballo, David Nanchen, Baris Gencer, Sebastian Carballo, Konstantinos C. Koskinas, Roland Klingenberg, Reto Auer
المساهمون: University of Zurich, Gencer, Baris
المصدر: Journal of the American Heart Association, vol. 6, no. 11, pp. NA
Gencer, Baris; Koskinas, Konstantinos C; Räber, Lorenz; Karagiannis, Alexios; Nanchen, David; Auer, Reto; Carballo, David; Carballo, Sebastian; Klingenberg, Roland; Heg, Dik; Matter, Christian M; Lüscher, Thomas F; Rodondi, Nicolas; Mach, François; Windecker, Stephan (2017). Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes. Journal of the American Heart Association, 6(11), e006537. American Heart Association 10.1161/JAHA.117.006537 <http://dx.doi.org/10.1161/JAHA.117.006537>
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Diseaseمصطلحات موضوعية: Male, Time Factors, Treatment outcome, Myocardial Infarction, Eligibility Determination, Apoptosis, 030204 cardiovascular system & hematology, PCSK9, 0302 clinical medicine, Medicine, Prospective Studies, 030212 general & internal medicine, Preventive Cardiology, PCSK9 Inhibitors, Societies, Medical, Original Research, Secondary prevention, Lipids and Cholesterol, Anticholesteremic Agents, Follow up studies, Acute Coronary Syndrome/blood, Acute Coronary Syndrome/drug therapy, Anticholesteremic Agents/administration & dosage, Cardiology, Cholesterol, LDL/blood, Dose-Response Relationship, Drug, Eligibility Determination/methods, Europe, Ezetimibe/administration & dosage, Female, Follow-Up Studies, Humans, Middle Aged, Practice Guidelines as Topic, Proprotein Convertase 9/antagonists & inhibitors, Treatment Outcome, United States, lipids, secondary prevention, 3. Good health, 10209 Clinic for Cardiology, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, medicine.medical_specialty, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, 360 Social problems & social services, Internal medicine, Acute Coronary Syndrome, Proprotein, business.industry, Cholesterol, LDL, Ezetimibe, European atherosclerosis society, business
وصف الملف: application/pdf; ZORA149776.pdf - application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6bde8c190ad0be7269ef60837924bd
https://serval.unil.ch/resource/serval:BIB_6ADD45556097.P001/REF.pdf -
4
المؤلفون: Dumas, Laurent S, Briand, François, Clerc, Romain, Brousseau, Emmanuel, Montemagno, Christopher, Ahmadi, Mitra, Bacot, Sandrine, Soubies, Audrey, Perret, Pascale, Riou, Laurent M, Devoogdt, Nick, Lahoutte, Tony, Baronne-Rochette, Gilles, Fagret, Daniel, Ghezzi, Catherine, Sulpice, Thierry, Broisat, Alexis
المساهمون: Translational Imaging Research Alliance, Medical Imaging, Supporting clinical sciences
مصطلحات موضوعية: drug monitoring, Mice, Knockout, Tomography, Emission-Computed, Single-Photon, Atherosclerosis/diagnostic imaging, mice, Ezetimibe/administration & dosage, Mice, Transgenic, Cholesterol, LDL, Diet, High-Fat, Tritium, Sensitivity and Specificity, Mice, Inbred C57BL, Feces, Treatment Outcome, Anticholesteremic Agents/administration & dosage, Isotope Labeling, Animals, lipids (amino acids, peptides, and proteins), Female, reproducibility of results, technetium, Apolipoproteins E/genetics
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3848::0410987423f94bee7b7aaa5e1f41f46c
https://doi.org/10.2967/jnumed.116.177279 -
5
المؤلفون: Hougaard, Mikkel, Hansen, Henrik Steen, Thayssen, Per, Antonsen, Lisbeth, Junker, Anders, Veien, Karsten, Jensen, Lisette Okkels
المصدر: Hougaard, M, Hansen, H S, Thayssen, P, Antonsen, L, Junker, A, Veien, K & Jensen, L O 2017, ' Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial Intravascular ultrasound with iMap: the OCTIVUS trial* ', Cardiovascular Revascularization Medicine, vol. 18, no. 2, pp. 110-117 . https://doi.org/10.1016/j.carrev.2016.11.010
مصطلحات موضوعية: IVUS, Male, Coronary Artery Disease/drug therapy, Ezetimibe/administration & dosage, Myocardial Infarction/drug therapy, Ultrasonography, Interventional/methods, Atorvastatin/administration & dosage, Middle Aged, Ezetimibe, Treatment Outcome, Atorvastatin, Humans, Female, Drug Therapy, Combination, iMap, Aged
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3062::f6586c209fad3cd4b876e22d5c8855f2
https://portal.findresearcher.sdu.dk/da/publications/3120ec25-2f67-4501-98d8-9bd8da0c9785 -
6
المؤلفون: Kurt Boman, Kristian Wachtell, Richard B. Devereux, Kenneth Egstrup, Simon Ray, Anders M. Greve, Christoph A. Nienaber, Casper N. Bang, Anne B. Rossebø, Peter M. Okin
المصدر: Bang, C N, Greve, A M, Rossebø, A B, Ray, S, Egstrup, K, Boman, K, Nienaber, C, Okin, P M, Devereux, R B & Wachtell, K 2017, ' Antihypertensive treatment with β-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events ', Journal of the American Heart Association, vol. 6, no. 12, e006709 . https://doi.org/10.1161/JAHA.117.006709
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Diseaseمصطلحات موضوعية: Male, Simvastatin, Aortic Valve Stenosis/complications, Blood Pressure, aortic valve stenosis, 030204 cardiovascular system & hematology, Arrhythmias, Heart Ventricles/diagnostic imaging, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage, 0302 clinical medicine, High blood pressure, Cause of Death, Anticholesteremic Agents/administration & dosage, Adrenergic beta-1 Receptor Antagonists/administration & dosage, Arrhythmia and Electrophysiology, atrial fibrillation, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Depression (differential diagnoses), Original Research, Aged, 80 and over, Survival Rate/trends, Kardiologi, Anticholesteremic Agents, Hypertension/drug therapy, Atrial fibrillation, Middle Aged, United States/epidemiology, Adrenergic beta-1 Receptor Antagonists, Echocardiography, Doppler, Survival Rate, Aortic valve stenosis, Cardiology, beta-blocker, Female, Morbidity/trends, Drug Therapy, Combination, medicine.symptom, Cardiology and Cardiovascular Medicine, Echocardiography, Doppler/methods, arrhythmia (heart rhythm disorders), medicine.medical_specialty, hypertension, Heart Ventricles, Cause of Death/trends, Asymptomatic, Simvastatin/administration & dosage, β‐blocker, Blood Pressure/drug effects, β blockade, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, high blood essure, Humans, In patient, Propensity Score, Aged, B-blocker, Dose-Response Relationship, Drug, business.industry, Ezetimibe/administration & dosage, medicine.disease, Ezetimibe, United States, Stenosis, Concomitant, Valvular Heart Disease, Asymptomatic Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Morbidity, business, high blood pressure
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595529e17fdd4235a7174ff5de07807d
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144421
Find this article in full text from Springer Verlag.